Metraipolis › archive › dc_ef4c9ecfd5e4

Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study — Europe PMC PMID:41501561

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41501561
DOI
10.1038/s41391-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-06T23:42:47.021Z
SHA-256 of the archived text
bfe363224c1db829d03f9170767c50325d5df25fd0e55a39cf6baeff12963e0c
Stable URL of this page
https://metraipolis.com/documento/dc_ef4c9ecfd5e4

How to cite

Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study — Europe PMC PMID:41501561 — Europe PMC (en), https://europepmc.org/article/MED/41501561 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef4c9ecfd5e4 (Metraipolis archive dc_ef4c9ecfd5e4, sha256 bfe363224c1db829d03f9170767c50325d5df25fd0e55a39cf6baeff12963e0c)
BibTeX
@misc{dcef4c9ecfd5e4,
  title = {Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study — Europe PMC PMID:41501561},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41501561},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef4c9ecfd5e4; sha256 bfe363224c1db829d03f9170767c50325d5df25fd0e55a39cf6baeff12963e0c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41501561. Agents can read the archived copy with the MCP tool read_document.